CA2670615C - Assay membrane and method of use thereof - Google Patents
Assay membrane and method of use thereof Download PDFInfo
- Publication number
- CA2670615C CA2670615C CA2670615A CA2670615A CA2670615C CA 2670615 C CA2670615 C CA 2670615C CA 2670615 A CA2670615 A CA 2670615A CA 2670615 A CA2670615 A CA 2670615A CA 2670615 C CA2670615 C CA 2670615C
- Authority
- CA
- Canada
- Prior art keywords
- antibody
- membrane
- control
- protein
- fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000003556 assay Methods 0.000 title claims abstract description 194
- 239000012528 membrane Substances 0.000 title claims abstract description 128
- 238000000034 method Methods 0.000 title claims description 39
- 238000001514 detection method Methods 0.000 claims abstract description 83
- 239000012491 analyte Substances 0.000 claims abstract description 65
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 62
- 239000013642 negative control Substances 0.000 claims abstract description 60
- 239000013641 positive control Substances 0.000 claims abstract description 37
- 239000012982 microporous membrane Substances 0.000 claims abstract description 30
- 238000002493 microarray Methods 0.000 claims abstract description 8
- 108091007433 antigens Proteins 0.000 claims description 155
- 102000036639 antigens Human genes 0.000 claims description 155
- 239000000427 antigen Substances 0.000 claims description 150
- 230000027455 binding Effects 0.000 claims description 89
- 235000018102 proteins Nutrition 0.000 claims description 87
- 102000004169 proteins and genes Human genes 0.000 claims description 87
- 108090000623 proteins and genes Proteins 0.000 claims description 87
- 102000004190 Enzymes Human genes 0.000 claims description 71
- 108090000790 Enzymes Proteins 0.000 claims description 71
- 239000003550 marker Substances 0.000 claims description 53
- 239000012634 fragment Substances 0.000 claims description 49
- 102000005962 receptors Human genes 0.000 claims description 44
- 108020003175 receptors Proteins 0.000 claims description 44
- 239000000758 substrate Substances 0.000 claims description 44
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 40
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 38
- 238000012545 processing Methods 0.000 claims description 38
- 239000003446 ligand Substances 0.000 claims description 35
- 201000010099 disease Diseases 0.000 claims description 31
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims description 29
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims description 29
- -1 OPG (Osteoprotegrin) Proteins 0.000 claims description 27
- 241000700605 Viruses Species 0.000 claims description 25
- 229960002685 biotin Drugs 0.000 claims description 23
- 239000011616 biotin Substances 0.000 claims description 23
- 235000020958 biotin Nutrition 0.000 claims description 20
- 210000004027 cell Anatomy 0.000 claims description 20
- 241000701022 Cytomegalovirus Species 0.000 claims description 16
- 108091008324 binding proteins Proteins 0.000 claims description 15
- 229940088597 hormone Drugs 0.000 claims description 15
- 239000005556 hormone Substances 0.000 claims description 15
- 230000002163 immunogen Effects 0.000 claims description 13
- 108010074051 C-Reactive Protein Proteins 0.000 claims description 12
- 239000003814 drug Substances 0.000 claims description 12
- 229910021645 metal ion Inorganic materials 0.000 claims description 12
- 102100032752 C-reactive protein Human genes 0.000 claims description 11
- 229940079593 drug Drugs 0.000 claims description 11
- 239000003102 growth factor Substances 0.000 claims description 11
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 11
- 208000002606 Paramyxoviridae Infections Diseases 0.000 claims description 10
- 108010090804 Streptavidin Proteins 0.000 claims description 10
- 208000006454 hepatitis Diseases 0.000 claims description 10
- 231100000283 hepatitis Toxicity 0.000 claims description 10
- 239000003112 inhibitor Substances 0.000 claims description 10
- 108090000978 Interleukin-4 Proteins 0.000 claims description 9
- 102000004388 Interleukin-4 Human genes 0.000 claims description 9
- 208000023275 Autoimmune disease Diseases 0.000 claims description 8
- 241000725303 Human immunodeficiency virus Species 0.000 claims description 8
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 8
- 108090001008 Avidin Proteins 0.000 claims description 7
- 108091034117 Oligonucleotide Proteins 0.000 claims description 7
- 241000725643 Respiratory syncytial virus Species 0.000 claims description 7
- 230000000890 antigenic effect Effects 0.000 claims description 7
- 208000035475 disorder Diseases 0.000 claims description 7
- 208000015181 infectious disease Diseases 0.000 claims description 7
- 244000005700 microbiome Species 0.000 claims description 7
- 230000011664 signaling Effects 0.000 claims description 7
- 208000035473 Communicable disease Diseases 0.000 claims description 6
- 108010067060 Immunoglobulin Variable Region Proteins 0.000 claims description 6
- 102000017727 Immunoglobulin Variable Region Human genes 0.000 claims description 6
- 108010081689 Osteopontin Proteins 0.000 claims description 6
- 102100035194 Placenta growth factor Human genes 0.000 claims description 6
- 102000040945 Transcription factor Human genes 0.000 claims description 6
- 108091023040 Transcription factor Proteins 0.000 claims description 6
- 150000002632 lipids Chemical class 0.000 claims description 6
- 229920001184 polypeptide Polymers 0.000 claims description 6
- 241000701161 unidentified adenovirus Species 0.000 claims description 6
- 101710132601 Capsid protein Proteins 0.000 claims description 5
- 208000024172 Cardiovascular disease Diseases 0.000 claims description 5
- 101000595923 Homo sapiens Placenta growth factor Proteins 0.000 claims description 5
- 102000003814 Interleukin-10 Human genes 0.000 claims description 5
- 108090000174 Interleukin-10 Proteins 0.000 claims description 5
- 108090001005 Interleukin-6 Proteins 0.000 claims description 5
- 102000004889 Interleukin-6 Human genes 0.000 claims description 5
- 108090001007 Interleukin-8 Proteins 0.000 claims description 5
- 102000004890 Interleukin-8 Human genes 0.000 claims description 5
- 108010011756 Milk Proteins Proteins 0.000 claims description 5
- 102000014171 Milk Proteins Human genes 0.000 claims description 5
- 108090000235 Myeloperoxidases Proteins 0.000 claims description 5
- 102000003896 Myeloperoxidases Human genes 0.000 claims description 5
- 206010028980 Neoplasm Diseases 0.000 claims description 5
- 241000700584 Simplexvirus Species 0.000 claims description 5
- 235000021239 milk protein Nutrition 0.000 claims description 5
- 229940044551 receptor antagonist Drugs 0.000 claims description 5
- 239000002464 receptor antagonist Substances 0.000 claims description 5
- 102100023701 C-C motif chemokine 18 Human genes 0.000 claims description 4
- 102100021943 C-C motif chemokine 2 Human genes 0.000 claims description 4
- 102100036850 C-C motif chemokine 23 Human genes 0.000 claims description 4
- 102100032367 C-C motif chemokine 5 Human genes 0.000 claims description 4
- 108010055166 Chemokine CCL5 Proteins 0.000 claims description 4
- 102000008946 Fibrinogen Human genes 0.000 claims description 4
- 208000009329 Graft vs Host Disease Diseases 0.000 claims description 4
- 101000713081 Homo sapiens C-C motif chemokine 23 Proteins 0.000 claims description 4
- 108090000176 Interleukin-13 Proteins 0.000 claims description 4
- 102000003816 Interleukin-13 Human genes 0.000 claims description 4
- 108010002350 Interleukin-2 Proteins 0.000 claims description 4
- 102000000588 Interleukin-2 Human genes 0.000 claims description 4
- 102000004856 Lectins Human genes 0.000 claims description 4
- 108090001090 Lectins Proteins 0.000 claims description 4
- 241000589902 Leptospira Species 0.000 claims description 4
- 101710151805 Mitochondrial intermediate peptidase 1 Proteins 0.000 claims description 4
- 241000588653 Neisseria Species 0.000 claims description 4
- 108010003723 Single-Domain Antibodies Proteins 0.000 claims description 4
- 208000026935 allergic disease Diseases 0.000 claims description 4
- 201000011510 cancer Diseases 0.000 claims description 4
- 230000008878 coupling Effects 0.000 claims description 4
- 238000010168 coupling process Methods 0.000 claims description 4
- 238000005859 coupling reaction Methods 0.000 claims description 4
- 229940012952 fibrinogen Drugs 0.000 claims description 4
- 208000024908 graft versus host disease Diseases 0.000 claims description 4
- 239000002523 lectin Substances 0.000 claims description 4
- 210000004185 liver Anatomy 0.000 claims description 4
- 229920002521 macromolecule Polymers 0.000 claims description 4
- 229920002704 polyhistidine Polymers 0.000 claims description 4
- 108010008064 pro-brain natriuretic peptide (1-76) Proteins 0.000 claims description 4
- 241000712461 unidentified influenza virus Species 0.000 claims description 4
- 230000003612 virological effect Effects 0.000 claims description 4
- 102000004506 Blood Proteins Human genes 0.000 claims description 3
- 108010017384 Blood Proteins Proteins 0.000 claims description 3
- 102100025248 C-X-C motif chemokine 10 Human genes 0.000 claims description 3
- 241000589876 Campylobacter Species 0.000 claims description 3
- 241000712083 Canine morbillivirus Species 0.000 claims description 3
- 101710094648 Coat protein Proteins 0.000 claims description 3
- 102100023688 Eotaxin Human genes 0.000 claims description 3
- 101710139422 Eotaxin Proteins 0.000 claims description 3
- 108010049003 Fibrinogen Proteins 0.000 claims description 3
- 102000003886 Glycoproteins Human genes 0.000 claims description 3
- 108090000288 Glycoproteins Proteins 0.000 claims description 3
- 102100021181 Golgi phosphoprotein 3 Human genes 0.000 claims description 3
- 102100034221 Growth-regulated alpha protein Human genes 0.000 claims description 3
- 101001076408 Homo sapiens Interleukin-6 Proteins 0.000 claims description 3
- 241000701074 Human alphaherpesvirus 2 Species 0.000 claims description 3
- 206010061218 Inflammation Diseases 0.000 claims description 3
- 101710125418 Major capsid protein Proteins 0.000 claims description 3
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 claims description 3
- 108010016113 Matrix Metalloproteinase 1 Proteins 0.000 claims description 3
- 102000012750 Membrane Glycoproteins Human genes 0.000 claims description 3
- 108010090054 Membrane Glycoproteins Proteins 0.000 claims description 3
- 102000018697 Membrane Proteins Human genes 0.000 claims description 3
- 108010052285 Membrane Proteins Proteins 0.000 claims description 3
- 101710141454 Nucleoprotein Proteins 0.000 claims description 3
- 108030001694 Pappalysin-1 Proteins 0.000 claims description 3
- 108010022233 Plasminogen Activator Inhibitor 1 Proteins 0.000 claims description 3
- 102100039418 Plasminogen activator inhibitor 1 Human genes 0.000 claims description 3
- 241000702619 Porcine parvovirus Species 0.000 claims description 3
- 102000005819 Pregnancy-Associated Plasma Protein-A Human genes 0.000 claims description 3
- 101710083689 Probable capsid protein Proteins 0.000 claims description 3
- 108010057464 Prolactin Proteins 0.000 claims description 3
- 241000589516 Pseudomonas Species 0.000 claims description 3
- 108010025832 RANK Ligand Proteins 0.000 claims description 3
- 102000014128 RANK Ligand Human genes 0.000 claims description 3
- 241000702670 Rotavirus Species 0.000 claims description 3
- 241000607142 Salmonella Species 0.000 claims description 3
- 241000701093 Suid alphaherpesvirus 1 Species 0.000 claims description 3
- 206010052779 Transplant rejections Diseases 0.000 claims description 3
- 150000001720 carbohydrates Chemical class 0.000 claims description 3
- 230000035558 fertility Effects 0.000 claims description 3
- 150000004676 glycans Chemical class 0.000 claims description 3
- 230000004054 inflammatory process Effects 0.000 claims description 3
- 108040006849 interleukin-2 receptor activity proteins Proteins 0.000 claims description 3
- 150000002772 monosaccharides Chemical class 0.000 claims description 3
- 229920001542 oligosaccharide Polymers 0.000 claims description 3
- 150000002482 oligosaccharides Chemical class 0.000 claims description 3
- 210000000056 organ Anatomy 0.000 claims description 3
- 229920001282 polysaccharide Polymers 0.000 claims description 3
- 239000005017 polysaccharide Substances 0.000 claims description 3
- 230000035935 pregnancy Effects 0.000 claims description 3
- 229940097325 prolactin Drugs 0.000 claims description 3
- 239000000018 receptor agonist Substances 0.000 claims description 3
- 229940044601 receptor agonist Drugs 0.000 claims description 3
- VKUYLANQOAKALN-UHFFFAOYSA-N 2-[benzyl-(4-methoxyphenyl)sulfonylamino]-n-hydroxy-4-methylpentanamide Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)N(C(CC(C)C)C(=O)NO)CC1=CC=CC=C1 VKUYLANQOAKALN-UHFFFAOYSA-N 0.000 claims description 2
- VOUAQYXWVJDEQY-QENPJCQMSA-N 33017-11-7 Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)CCC1 VOUAQYXWVJDEQY-QENPJCQMSA-N 0.000 claims description 2
- 102100026802 72 kDa type IV collagenase Human genes 0.000 claims description 2
- 101710151806 72 kDa type IV collagenase Proteins 0.000 claims description 2
- 102000011690 Adiponectin Human genes 0.000 claims description 2
- 108010076365 Adiponectin Proteins 0.000 claims description 2
- 102100038778 Amphiregulin Human genes 0.000 claims description 2
- 108010033760 Amphiregulin Proteins 0.000 claims description 2
- 108010059886 Apolipoprotein A-I Proteins 0.000 claims description 2
- 102000005666 Apolipoprotein A-I Human genes 0.000 claims description 2
- 108010008150 Apolipoprotein B-100 Proteins 0.000 claims description 2
- 102100040202 Apolipoprotein B-100 Human genes 0.000 claims description 2
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 2
- 108010081589 Becaplermin Proteins 0.000 claims description 2
- 208000035049 Blood-Borne Infections Diseases 0.000 claims description 2
- 108090000715 Brain-derived neurotrophic factor Proteins 0.000 claims description 2
- 102000004219 Brain-derived neurotrophic factor Human genes 0.000 claims description 2
- 241000589562 Brucella Species 0.000 claims description 2
- 102100023702 C-C motif chemokine 13 Human genes 0.000 claims description 2
- 101710112613 C-C motif chemokine 13 Proteins 0.000 claims description 2
- 102100023700 C-C motif chemokine 16 Human genes 0.000 claims description 2
- 102100023698 C-C motif chemokine 17 Human genes 0.000 claims description 2
- 101710155857 C-C motif chemokine 2 Proteins 0.000 claims description 2
- 102100036846 C-C motif chemokine 21 Human genes 0.000 claims description 2
- 102100036849 C-C motif chemokine 24 Human genes 0.000 claims description 2
- 102100032366 C-C motif chemokine 7 Human genes 0.000 claims description 2
- 101710155834 C-C motif chemokine 7 Proteins 0.000 claims description 2
- 102100034871 C-C motif chemokine 8 Human genes 0.000 claims description 2
- 101710155833 C-C motif chemokine 8 Proteins 0.000 claims description 2
- 108010075254 C-Peptide Proteins 0.000 claims description 2
- 101710098275 C-X-C motif chemokine 10 Proteins 0.000 claims description 2
- 102100025279 C-X-C motif chemokine 11 Human genes 0.000 claims description 2
- 102100036150 C-X-C motif chemokine 5 Human genes 0.000 claims description 2
- 102100036170 C-X-C motif chemokine 9 Human genes 0.000 claims description 2
- 101710085500 C-X-C motif chemokine 9 Proteins 0.000 claims description 2
- 108010029697 CD40 Ligand Proteins 0.000 claims description 2
- 102100032937 CD40 ligand Human genes 0.000 claims description 2
- 102000000905 Cadherin Human genes 0.000 claims description 2
- 108050007957 Cadherin Proteins 0.000 claims description 2
- 108010082155 Chemokine CCL18 Proteins 0.000 claims description 2
- 108010083647 Chemokine CCL24 Proteins 0.000 claims description 2
- 241000588881 Chromobacterium Species 0.000 claims description 2
- 108010005939 Ciliary Neurotrophic Factor Proteins 0.000 claims description 2
- 102100031614 Ciliary neurotrophic factor Human genes 0.000 claims description 2
- 241000193403 Clostridium Species 0.000 claims description 2
- 102100027995 Collagenase 3 Human genes 0.000 claims description 2
- 108050005238 Collagenase 3 Proteins 0.000 claims description 2
- 102100031107 Disintegrin and metalloproteinase domain-containing protein 11 Human genes 0.000 claims description 2
- 101710121366 Disintegrin and metalloproteinase domain-containing protein 11 Proteins 0.000 claims description 2
- 108010024212 E-Selectin Proteins 0.000 claims description 2
- 102100023471 E-selectin Human genes 0.000 claims description 2
- 241000588914 Enterobacter Species 0.000 claims description 2
- 241000194033 Enterococcus Species 0.000 claims description 2
- 241000588722 Escherichia Species 0.000 claims description 2
- 108010039471 Fas Ligand Protein Proteins 0.000 claims description 2
- 108090000385 Fibroblast growth factor 7 Proteins 0.000 claims description 2
- 102100037362 Fibronectin Human genes 0.000 claims description 2
- 108010067306 Fibronectins Proteins 0.000 claims description 2
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 claims description 2
- 102100039619 Granulocyte colony-stimulating factor Human genes 0.000 claims description 2
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims description 2
- 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 claims description 2
- 102400001369 Heparin-binding EGF-like growth factor Human genes 0.000 claims description 2
- 101800001649 Heparin-binding EGF-like growth factor Proteins 0.000 claims description 2
- 101000978375 Homo sapiens C-C motif chemokine 16 Proteins 0.000 claims description 2
- 101000978362 Homo sapiens C-C motif chemokine 17 Proteins 0.000 claims description 2
- 101000713085 Homo sapiens C-C motif chemokine 21 Proteins 0.000 claims description 2
- 101000947186 Homo sapiens C-X-C motif chemokine 5 Proteins 0.000 claims description 2
- 101100222381 Homo sapiens CXCL11 gene Proteins 0.000 claims description 2
- 101000898034 Homo sapiens Hepatocyte growth factor Proteins 0.000 claims description 2
- 101000973997 Homo sapiens Nucleosome assembly protein 1-like 4 Proteins 0.000 claims description 2
- 101000947178 Homo sapiens Platelet basic protein Proteins 0.000 claims description 2
- 101000668165 Homo sapiens RNA-binding motif, single-stranded-interacting protein 1 Proteins 0.000 claims description 2
- 101000868152 Homo sapiens Son of sevenless homolog 1 Proteins 0.000 claims description 2
- 101100369992 Homo sapiens TNFSF10 gene Proteins 0.000 claims description 2
- 101000851376 Homo sapiens Tumor necrosis factor receptor superfamily member 8 Proteins 0.000 claims description 2
- 206010020751 Hypersensitivity Diseases 0.000 claims description 2
- 102000004374 Insulin-like growth factor binding protein 3 Human genes 0.000 claims description 2
- 108090000965 Insulin-like growth factor binding protein 3 Proteins 0.000 claims description 2
- 102000004375 Insulin-like growth factor-binding protein 1 Human genes 0.000 claims description 2
- 108090000957 Insulin-like growth factor-binding protein 1 Proteins 0.000 claims description 2
- 108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 claims description 2
- 102000015271 Intercellular Adhesion Molecule-1 Human genes 0.000 claims description 2
- 108090000177 Interleukin-11 Proteins 0.000 claims description 2
- 102000003815 Interleukin-11 Human genes 0.000 claims description 2
- 102000014158 Interleukin-12 Subunit p40 Human genes 0.000 claims description 2
- 108010011429 Interleukin-12 Subunit p40 Proteins 0.000 claims description 2
- 102000003812 Interleukin-15 Human genes 0.000 claims description 2
- 108090000172 Interleukin-15 Proteins 0.000 claims description 2
- 102000049772 Interleukin-16 Human genes 0.000 claims description 2
- 101800003050 Interleukin-16 Proteins 0.000 claims description 2
- 108050003558 Interleukin-17 Proteins 0.000 claims description 2
- 102000013691 Interleukin-17 Human genes 0.000 claims description 2
- 102000003810 Interleukin-18 Human genes 0.000 claims description 2
- 108090000171 Interleukin-18 Proteins 0.000 claims description 2
- 108010002386 Interleukin-3 Proteins 0.000 claims description 2
- 102100037792 Interleukin-6 receptor subunit alpha Human genes 0.000 claims description 2
- 108010002586 Interleukin-7 Proteins 0.000 claims description 2
- 108010002335 Interleukin-9 Proteins 0.000 claims description 2
- 102000000585 Interleukin-9 Human genes 0.000 claims description 2
- 241001454354 Kingella Species 0.000 claims description 2
- 108010092694 L-Selectin Proteins 0.000 claims description 2
- 102100033467 L-selectin Human genes 0.000 claims description 2
- 108010031801 Lipopolysaccharide Receptors Proteins 0.000 claims description 2
- 102000005482 Lipopolysaccharide Receptors Human genes 0.000 claims description 2
- 102100035304 Lymphotactin Human genes 0.000 claims description 2
- 102000034655 MIF Human genes 0.000 claims description 2
- 108060004872 MIF Proteins 0.000 claims description 2
- 102100030417 Matrilysin Human genes 0.000 claims description 2
- 108090000855 Matrilysin Proteins 0.000 claims description 2
- 102100030412 Matrix metalloproteinase-9 Human genes 0.000 claims description 2
- 108010015302 Matrix metalloproteinase-9 Proteins 0.000 claims description 2
- 102100039364 Metalloproteinase inhibitor 1 Human genes 0.000 claims description 2
- 102100026262 Metalloproteinase inhibitor 2 Human genes 0.000 claims description 2
- 241000588621 Moraxella Species 0.000 claims description 2
- 241000186359 Mycobacterium Species 0.000 claims description 2
- 102400001263 NT-proBNP Human genes 0.000 claims description 2
- 108090000742 Neurotrophin 3 Proteins 0.000 claims description 2
- 102100030411 Neutrophil collagenase Human genes 0.000 claims description 2
- 101710118230 Neutrophil collagenase Proteins 0.000 claims description 2
- 108010035766 P-Selectin Proteins 0.000 claims description 2
- 102100023472 P-selectin Human genes 0.000 claims description 2
- 241000710778 Pestivirus Species 0.000 claims description 2
- 241000224016 Plasmodium Species 0.000 claims description 2
- 102100036154 Platelet basic protein Human genes 0.000 claims description 2
- 241000588769 Proteus <enterobacteria> Species 0.000 claims description 2
- 102000007156 Resistin Human genes 0.000 claims description 2
- 108010047909 Resistin Proteins 0.000 claims description 2
- 206010062106 Respiratory tract infection viral Diseases 0.000 claims description 2
- 206010057190 Respiratory tract infections Diseases 0.000 claims description 2
- 241001478225 Riemerella Species 0.000 claims description 2
- 241000710799 Rubella virus Species 0.000 claims description 2
- 208000019802 Sexually transmitted disease Diseases 0.000 claims description 2
- 241000863011 Simonsiella Species 0.000 claims description 2
- 102100032889 Sortilin Human genes 0.000 claims description 2
- 241000191940 Staphylococcus Species 0.000 claims description 2
- 241000194017 Streptococcus Species 0.000 claims description 2
- 102100021669 Stromal cell-derived factor 1 Human genes 0.000 claims description 2
- 101710088580 Stromal cell-derived factor 1 Proteins 0.000 claims description 2
- 102100030416 Stromelysin-1 Human genes 0.000 claims description 2
- 101710108790 Stromelysin-1 Proteins 0.000 claims description 2
- 102100028848 Stromelysin-2 Human genes 0.000 claims description 2
- 101710108792 Stromelysin-2 Proteins 0.000 claims description 2
- 108700012411 TNFSF10 Proteins 0.000 claims description 2
- 108010000499 Thromboplastin Proteins 0.000 claims description 2
- 102000002262 Thromboplastin Human genes 0.000 claims description 2
- 102100027188 Thyroid peroxidase Human genes 0.000 claims description 2
- 101710113649 Thyroid peroxidase Proteins 0.000 claims description 2
- 108010031374 Tissue Inhibitor of Metalloproteinase-1 Proteins 0.000 claims description 2
- 108010031372 Tissue Inhibitor of Metalloproteinase-2 Proteins 0.000 claims description 2
- 241000223996 Toxoplasma Species 0.000 claims description 2
- 241000223997 Toxoplasma gondii Species 0.000 claims description 2
- 241000589886 Treponema Species 0.000 claims description 2
- 241000223104 Trypanosoma Species 0.000 claims description 2
- 102100031988 Tumor necrosis factor ligand superfamily member 6 Human genes 0.000 claims description 2
- 101710187743 Tumor necrosis factor receptor superfamily member 1A Proteins 0.000 claims description 2
- 102100033732 Tumor necrosis factor receptor superfamily member 1A Human genes 0.000 claims description 2
- 101710187830 Tumor necrosis factor receptor superfamily member 1B Proteins 0.000 claims description 2
- 102100033733 Tumor necrosis factor receptor superfamily member 1B Human genes 0.000 claims description 2
- 102100036857 Tumor necrosis factor receptor superfamily member 8 Human genes 0.000 claims description 2
- 108010000134 Vascular Cell Adhesion Molecule-1 Proteins 0.000 claims description 2
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims description 2
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims description 2
- 102100023543 Vascular cell adhesion protein 1 Human genes 0.000 claims description 2
- 230000001154 acute effect Effects 0.000 claims description 2
- 230000007815 allergy Effects 0.000 claims description 2
- 206010022000 influenza Diseases 0.000 claims description 2
- 108040006858 interleukin-6 receptor activity proteins Proteins 0.000 claims description 2
- 108010019677 lymphotactin Proteins 0.000 claims description 2
- AEUKDPKXTPNBNY-XEYRWQBLSA-N mcp 2 Chemical compound C([C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)C1=CC=CC=C1 AEUKDPKXTPNBNY-XEYRWQBLSA-N 0.000 claims description 2
- 102000023732 binding proteins Human genes 0.000 claims 4
- 108010002352 Interleukin-1 Proteins 0.000 claims 2
- 102000000589 Interleukin-1 Human genes 0.000 claims 2
- 102100040557 Osteopontin Human genes 0.000 claims 2
- 108091006024 signal transducing proteins Proteins 0.000 claims 2
- 102000034285 signal transducing proteins Human genes 0.000 claims 2
- 102100036841 C-C motif chemokine 1 Human genes 0.000 claims 1
- 101150093802 CXCL1 gene Proteins 0.000 claims 1
- 102000009024 Epidermal Growth Factor Human genes 0.000 claims 1
- 101000713104 Homo sapiens C-C motif chemokine 1 Proteins 0.000 claims 1
- 101000959820 Homo sapiens Interferon alpha-1/13 Proteins 0.000 claims 1
- 241000700588 Human alphaherpesvirus 1 Species 0.000 claims 1
- 102100040019 Interferon alpha-1/13 Human genes 0.000 claims 1
- 108010002616 Interleukin-5 Proteins 0.000 claims 1
- 101710098940 Pro-epidermal growth factor Proteins 0.000 claims 1
- 102000003946 Prolactin Human genes 0.000 claims 1
- 102100024598 Tumor necrosis factor ligand superfamily member 10 Human genes 0.000 claims 1
- 102000009634 interleukin-1 receptor antagonist activity proteins Human genes 0.000 claims 1
- 108040001669 interleukin-1 receptor antagonist activity proteins Proteins 0.000 claims 1
- 239000000090 biomarker Substances 0.000 abstract description 41
- 239000012472 biological sample Substances 0.000 abstract description 8
- 238000012216 screening Methods 0.000 abstract description 6
- 230000009260 cross reactivity Effects 0.000 abstract description 4
- 238000003018 immunoassay Methods 0.000 abstract description 4
- 230000035945 sensitivity Effects 0.000 abstract description 4
- 238000012360 testing method Methods 0.000 description 117
- 239000000523 sample Substances 0.000 description 86
- 229940088598 enzyme Drugs 0.000 description 85
- 238000003491 array Methods 0.000 description 70
- 238000007792 addition Methods 0.000 description 49
- 210000002966 serum Anatomy 0.000 description 46
- 239000000872 buffer Substances 0.000 description 36
- 239000013566 allergen Substances 0.000 description 34
- 208000002672 hepatitis B Diseases 0.000 description 32
- 238000010790 dilution Methods 0.000 description 26
- 239000012895 dilution Substances 0.000 description 26
- 102000013415 peroxidase activity proteins Human genes 0.000 description 25
- 108040007629 peroxidase activity proteins Proteins 0.000 description 25
- 241000894007 species Species 0.000 description 20
- 102000004127 Cytokines Human genes 0.000 description 18
- 108090000695 Cytokines Proteins 0.000 description 18
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 18
- 230000006870 function Effects 0.000 description 17
- 241000699666 Mus <mouse, genus> Species 0.000 description 16
- 241000283707 Capra Species 0.000 description 14
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 13
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 229960004784 allergens Drugs 0.000 description 12
- 230000000295 complement effect Effects 0.000 description 12
- 239000000975 dye Substances 0.000 description 12
- 208000037797 influenza A Diseases 0.000 description 12
- 239000000463 material Substances 0.000 description 12
- 102000014914 Carrier Proteins Human genes 0.000 description 11
- 241001465754 Metazoa Species 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 11
- 238000007639 printing Methods 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- 210000001519 tissue Anatomy 0.000 description 11
- 238000011282 treatment Methods 0.000 description 11
- 241000283690 Bos taurus Species 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 10
- 238000011534 incubation Methods 0.000 description 10
- 240000003291 Armoracia rusticana Species 0.000 description 9
- 235000011330 Armoracia rusticana Nutrition 0.000 description 9
- 238000002965 ELISA Methods 0.000 description 9
- SXEHKFHPFVVDIR-UHFFFAOYSA-N [4-(4-hydrazinylphenyl)phenyl]hydrazine Chemical compound C1=CC(NN)=CC=C1C1=CC=C(NN)C=C1 SXEHKFHPFVVDIR-UHFFFAOYSA-N 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- 102000015696 Interleukins Human genes 0.000 description 8
- 108010063738 Interleukins Proteins 0.000 description 8
- 229920001213 Polysorbate 20 Polymers 0.000 description 8
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 8
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 8
- 208000037798 influenza B Diseases 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 238000012544 monitoring process Methods 0.000 description 8
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 8
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 8
- 238000013461 design Methods 0.000 description 7
- 238000002405 diagnostic procedure Methods 0.000 description 7
- 238000010586 diagram Methods 0.000 description 7
- 230000003993 interaction Effects 0.000 description 7
- 239000002184 metal Substances 0.000 description 7
- 229910052751 metal Inorganic materials 0.000 description 7
- 238000012546 transfer Methods 0.000 description 7
- 241000699800 Cricetinae Species 0.000 description 6
- 239000004677 Nylon Substances 0.000 description 6
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 6
- 230000000903 blocking effect Effects 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
- 229920001778 nylon Polymers 0.000 description 6
- 210000002381 plasma Anatomy 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 238000010200 validation analysis Methods 0.000 description 6
- 239000011534 wash buffer Substances 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- 241000251468 Actinopterygii Species 0.000 description 5
- 102000019034 Chemokines Human genes 0.000 description 5
- 108010012236 Chemokines Proteins 0.000 description 5
- 241000238557 Decapoda Species 0.000 description 5
- 108060003951 Immunoglobulin Proteins 0.000 description 5
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 5
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 5
- 235000019688 fish Nutrition 0.000 description 5
- 102000018358 immunoglobulin Human genes 0.000 description 5
- 239000002953 phosphate buffered saline Substances 0.000 description 5
- 230000000241 respiratory effect Effects 0.000 description 5
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 4
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 4
- 241000282465 Canis Species 0.000 description 4
- 108010076119 Caseins Proteins 0.000 description 4
- 108020004414 DNA Proteins 0.000 description 4
- 108010015776 Glucose oxidase Proteins 0.000 description 4
- 239000004366 Glucose oxidase Substances 0.000 description 4
- 102000004264 Osteopontin Human genes 0.000 description 4
- 239000004793 Polystyrene Substances 0.000 description 4
- 108010061174 Thyrotropin Proteins 0.000 description 4
- 102000011923 Thyrotropin Human genes 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 239000005018 casein Substances 0.000 description 4
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 4
- 235000021240 caseins Nutrition 0.000 description 4
- 229920002301 cellulose acetate Polymers 0.000 description 4
- 239000002131 composite material Substances 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 229940116332 glucose oxidase Drugs 0.000 description 4
- 235000019420 glucose oxidase Nutrition 0.000 description 4
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 101710135378 pH 6 antigen Proteins 0.000 description 4
- 229920002223 polystyrene Polymers 0.000 description 4
- 229960003604 testosterone Drugs 0.000 description 4
- 241000238876 Acari Species 0.000 description 3
- 101710145634 Antigen 1 Proteins 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- 208000020446 Cardiac disease Diseases 0.000 description 3
- 102000053602 DNA Human genes 0.000 description 3
- 229920002307 Dextran Polymers 0.000 description 3
- 241000283073 Equus caballus Species 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- 108010051696 Growth Hormone Proteins 0.000 description 3
- 102000014702 Haptoglobin Human genes 0.000 description 3
- 108050005077 Haptoglobin Proteins 0.000 description 3
- 241000713340 Human immunodeficiency virus 2 Species 0.000 description 3
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- 239000000020 Nitrocellulose Substances 0.000 description 3
- 239000004695 Polyether sulfone Substances 0.000 description 3
- 102100038803 Somatotropin Human genes 0.000 description 3
- 101000874347 Streptococcus agalactiae IgA FC receptor Proteins 0.000 description 3
- 241000282887 Suidae Species 0.000 description 3
- 230000003092 anti-cytokine Effects 0.000 description 3
- 229940098773 bovine serum albumin Drugs 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 238000012790 confirmation Methods 0.000 description 3
- 239000000428 dust Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 239000000122 growth hormone Substances 0.000 description 3
- 208000019622 heart disease Diseases 0.000 description 3
- 229940125396 insulin Drugs 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 229920001220 nitrocellulos Polymers 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 229920000515 polycarbonate Polymers 0.000 description 3
- 239000004417 polycarbonate Substances 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 229920006393 polyether sulfone Polymers 0.000 description 3
- 239000000186 progesterone Substances 0.000 description 3
- 229960003387 progesterone Drugs 0.000 description 3
- 239000007790 solid phase Substances 0.000 description 3
- 230000009870 specific binding Effects 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 241001529453 unidentified herpesvirus Species 0.000 description 3
- 231100000611 venom Toxicity 0.000 description 3
- 244000052613 viral pathogen Species 0.000 description 3
- 210000002845 virion Anatomy 0.000 description 3
- ROICYBLUWUMJFF-RDTXWAMCSA-N (6aR,9R)-N,7-dimethyl-N-propan-2-yl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide Chemical compound CN(C(=O)[C@H]1CN(C)[C@@H]2CC3=CNC4=CC=CC(C2=C1)=C34)C(C)C ROICYBLUWUMJFF-RDTXWAMCSA-N 0.000 description 2
- UAIUNKRWKOVEES-UHFFFAOYSA-N 3,3',5,5'-tetramethylbenzidine Chemical compound CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 UAIUNKRWKOVEES-UHFFFAOYSA-N 0.000 description 2
- VKYZDCTWJGBFDW-UHFFFAOYSA-N 4-chloro-2-methylaniline;hydron;chloride Chemical compound Cl.CC1=CC(Cl)=CC=C1N VKYZDCTWJGBFDW-UHFFFAOYSA-N 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- 241000605281 Anaplasma phagocytophilum Species 0.000 description 2
- 241000271566 Aves Species 0.000 description 2
- 241000193738 Bacillus anthracis Species 0.000 description 2
- 241000589968 Borrelia Species 0.000 description 2
- 241001148604 Borreliella afzelii Species 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 108010022366 Carcinoembryonic Antigen Proteins 0.000 description 2
- 102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 description 2
- 102000011022 Chorionic Gonadotropin Human genes 0.000 description 2
- 108010062540 Chorionic Gonadotropin Proteins 0.000 description 2
- 102000004420 Creatine Kinase Human genes 0.000 description 2
- 108010042126 Creatine kinase Proteins 0.000 description 2
- 102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 description 2
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 2
- 101000968532 Dictyocaulus viviparus DVA-1 polyprotein Proteins 0.000 description 2
- 102100037738 Fatty acid-binding protein, heart Human genes 0.000 description 2
- 101710136552 Fatty acid-binding protein, heart Proteins 0.000 description 2
- 241000701087 Felid alphaherpesvirus 1 Species 0.000 description 2
- 241000725579 Feline coronavirus Species 0.000 description 2
- 241000700721 Hepatitis B virus Species 0.000 description 2
- 241000709721 Hepatovirus A Species 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 101000889276 Homo sapiens Cytotoxic T-lymphocyte protein 4 Proteins 0.000 description 2
- 108091058560 IL8 Proteins 0.000 description 2
- 108010065805 Interleukin-12 Proteins 0.000 description 2
- 102000013462 Interleukin-12 Human genes 0.000 description 2
- 241000222727 Leishmania donovani Species 0.000 description 2
- 108010092277 Leptin Proteins 0.000 description 2
- 102000016267 Leptin Human genes 0.000 description 2
- 208000016604 Lyme disease Diseases 0.000 description 2
- 101710091439 Major capsid protein 1 Proteins 0.000 description 2
- 102100022185 Melanoma-derived growth regulatory protein Human genes 0.000 description 2
- 101710195116 Melanoma-derived growth regulatory protein Proteins 0.000 description 2
- 241000588652 Neisseria gonorrhoeae Species 0.000 description 2
- 102000019040 Nuclear Antigens Human genes 0.000 description 2
- 108010051791 Nuclear Antigens Proteins 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 108090000445 Parathyroid hormone Proteins 0.000 description 2
- 102000003982 Parathyroid hormone Human genes 0.000 description 2
- 241000223960 Plasmodium falciparum Species 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 102100024819 Prolactin Human genes 0.000 description 2
- 108010072866 Prostate-Specific Antigen Proteins 0.000 description 2
- 102100038358 Prostate-specific antigen Human genes 0.000 description 2
- 244000088415 Raphanus sativus Species 0.000 description 2
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 2
- 108010071390 Serum Albumin Proteins 0.000 description 2
- 102000007562 Serum Albumin Human genes 0.000 description 2
- 108700028909 Serum Amyloid A Proteins 0.000 description 2
- 102000054727 Serum Amyloid A Human genes 0.000 description 2
- 102000004598 Small Nuclear Ribonucleoproteins Human genes 0.000 description 2
- 108010003165 Small Nuclear Ribonucleoproteins Proteins 0.000 description 2
- 108010073771 Soybean Proteins Proteins 0.000 description 2
- 108010057517 Strep-avidin conjugated horseradish peroxidase Proteins 0.000 description 2
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical compound IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 description 2
- 241000589884 Treponema pallidum Species 0.000 description 2
- 241000223109 Trypanosoma cruzi Species 0.000 description 2
- 101710123661 Venom allergen 5 Proteins 0.000 description 2
- 206010051511 Viral diarrhoea Diseases 0.000 description 2
- 241000607479 Yersinia pestis Species 0.000 description 2
- IOMLBTHPCVDRHM-UHFFFAOYSA-N [3-[(2,4-dimethylphenyl)carbamoyl]naphthalen-2-yl] dihydrogen phosphate Chemical compound CC1=CC(C)=CC=C1NC(=O)C1=CC2=CC=CC=C2C=C1OP(O)(O)=O IOMLBTHPCVDRHM-UHFFFAOYSA-N 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 102000013529 alpha-Fetoproteins Human genes 0.000 description 2
- 108010026331 alpha-Fetoproteins Proteins 0.000 description 2
- 238000002820 assay format Methods 0.000 description 2
- 230000001588 bifunctional effect Effects 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 108700021042 biotin binding protein Proteins 0.000 description 2
- 102000043871 biotin binding protein Human genes 0.000 description 2
- 239000002981 blocking agent Substances 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 201000011529 cardiovascular cancer Diseases 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 2
- 229960004407 chorionic gonadotrophin Drugs 0.000 description 2
- 238000004737 colorimetric analysis Methods 0.000 description 2
- 238000012875 competitive assay Methods 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 210000000416 exudates and transudate Anatomy 0.000 description 2
- 229940046528 grass pollen Drugs 0.000 description 2
- 208000024348 heart neoplasm Diseases 0.000 description 2
- 229940084986 human chorionic gonadotropin Drugs 0.000 description 2
- 229960000890 hydrocortisone Drugs 0.000 description 2
- 229940072221 immunoglobulins Drugs 0.000 description 2
- 239000012678 infectious agent Substances 0.000 description 2
- 239000002919 insect venom Substances 0.000 description 2
- 235000021374 legumes Nutrition 0.000 description 2
- 229940039781 leptin Drugs 0.000 description 2
- NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 210000002445 nipple Anatomy 0.000 description 2
- FSVCQIDHPKZJSO-UHFFFAOYSA-L nitro blue tetrazolium dichloride Chemical compound [Cl-].[Cl-].COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 FSVCQIDHPKZJSO-UHFFFAOYSA-L 0.000 description 2
- 235000014571 nuts Nutrition 0.000 description 2
- 150000004995 p-toluidines Chemical class 0.000 description 2
- 239000000199 parathyroid hormone Substances 0.000 description 2
- 229960001319 parathyroid hormone Drugs 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 2
- 238000010188 recombinant method Methods 0.000 description 2
- 239000003488 releasing hormone Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 229960004641 rituximab Drugs 0.000 description 2
- 235000014102 seafood Nutrition 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 235000020183 skimmed milk Nutrition 0.000 description 2
- 229940001941 soy protein Drugs 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000002626 targeted therapy Methods 0.000 description 2
- 239000005495 thyroid hormone Substances 0.000 description 2
- 229940036555 thyroid hormone Drugs 0.000 description 2
- 229940034208 thyroxine Drugs 0.000 description 2
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 2
- 229940046536 tree pollen allergenic extract Drugs 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- PROQIPRRNZUXQM-UHFFFAOYSA-N (16alpha,17betaOH)-Estra-1,3,5(10)-triene-3,16,17-triol Natural products OC1=CC=C2C3CCC(C)(C(C(O)C4)O)C4C3CCC2=C1 PROQIPRRNZUXQM-UHFFFAOYSA-N 0.000 description 1
- HMLGSIZOMSVISS-ONJSNURVSA-N (7r)-7-[[(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-(2,2-dimethylpropanoyloxymethoxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound N([C@@H]1C(N2C(=C(C=C)CSC21)C(O)=O)=O)C(=O)\C(=N/OCOC(=O)C(C)(C)C)C1=CSC(N)=N1 HMLGSIZOMSVISS-ONJSNURVSA-N 0.000 description 1
- PXGPLTODNUVGFL-BRIYLRKRSA-N (E,Z)-(1R,2R,3R,5S)-7-(3,5-Dihydroxy-2-((3S)-(3-hydroxy-1-octenyl))cyclopentyl)-5-heptenoic acid Chemical compound CCCCC[C@H](O)C=C[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC=CCCCC(O)=O PXGPLTODNUVGFL-BRIYLRKRSA-N 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- JKKFKPJIXZFSSB-UHFFFAOYSA-N 1,3,5(10)-estratrien-17-one 3-sulfate Natural products OS(=O)(=O)OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 JKKFKPJIXZFSSB-UHFFFAOYSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- BHNQPLPANNDEGL-UHFFFAOYSA-N 2-(4-octylphenoxy)ethanol Chemical compound CCCCCCCCC1=CC=C(OCCO)C=C1 BHNQPLPANNDEGL-UHFFFAOYSA-N 0.000 description 1
- RTQWWZBSTRGEAV-PKHIMPSTSA-N 2-[[(2s)-2-[bis(carboxymethyl)amino]-3-[4-(methylcarbamoylamino)phenyl]propyl]-[2-[bis(carboxymethyl)amino]propyl]amino]acetic acid Chemical compound CNC(=O)NC1=CC=C(C[C@@H](CN(CC(C)N(CC(O)=O)CC(O)=O)CC(O)=O)N(CC(O)=O)CC(O)=O)C=C1 RTQWWZBSTRGEAV-PKHIMPSTSA-N 0.000 description 1
- UMCMPZBLKLEWAF-BCTGSCMUSA-N 3-[(3-cholamidopropyl)dimethylammonio]propane-1-sulfonate Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCC[N+](C)(C)CCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 UMCMPZBLKLEWAF-BCTGSCMUSA-N 0.000 description 1
- QFVHZQCOUORWEI-UHFFFAOYSA-N 4-[(4-anilino-5-sulfonaphthalen-1-yl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonic acid Chemical compound C=12C(O)=CC(S(O)(=O)=O)=CC2=CC(S(O)(=O)=O)=CC=1N=NC(C1=CC=CC(=C11)S(O)(=O)=O)=CC=C1NC1=CC=CC=C1 QFVHZQCOUORWEI-UHFFFAOYSA-N 0.000 description 1
- LVSPDZAGCBEQAV-UHFFFAOYSA-N 4-chloronaphthalen-1-ol Chemical compound C1=CC=C2C(O)=CC=C(Cl)C2=C1 LVSPDZAGCBEQAV-UHFFFAOYSA-N 0.000 description 1
- USSIQXCVUWKGNF-UHFFFAOYSA-N 6-(dimethylamino)-4,4-diphenylheptan-3-one Chemical compound C=1C=CC=CC=1C(CC(C)N(C)C)(C(=O)CC)C1=CC=CC=C1 USSIQXCVUWKGNF-UHFFFAOYSA-N 0.000 description 1
- XGWFJBFNAQHLEF-UHFFFAOYSA-N 9-anthroic acid Chemical compound C1=CC=C2C(C(=O)O)=C(C=CC=C3)C3=CC2=C1 XGWFJBFNAQHLEF-UHFFFAOYSA-N 0.000 description 1
- 239000000275 Adrenocorticotropic Hormone Substances 0.000 description 1
- PQSUYGKTWSAVDQ-UHFFFAOYSA-N Aldosterone Natural products C1CC2C3CCC(C(=O)CO)C3(C=O)CC(O)C2C2(C)C1=CC(=O)CC2 PQSUYGKTWSAVDQ-UHFFFAOYSA-N 0.000 description 1
- PQSUYGKTWSAVDQ-ZVIOFETBSA-N Aldosterone Chemical compound C([C@@]1([C@@H](C(=O)CO)CC[C@H]1[C@@H]1CC2)C=O)[C@H](O)[C@@H]1[C@]1(C)C2=CC(=O)CC1 PQSUYGKTWSAVDQ-ZVIOFETBSA-N 0.000 description 1
- 206010001935 American trypanosomiasis Diseases 0.000 description 1
- 108010064733 Angiotensins Proteins 0.000 description 1
- 102000015427 Angiotensins Human genes 0.000 description 1
- 208000031295 Animal disease Diseases 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 101100339431 Arabidopsis thaliana HMGB2 gene Proteins 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 241001519465 Avian metapneumovirus Species 0.000 description 1
- 241001516406 Avian orthoreovirus Species 0.000 description 1
- 241000223775 Babesia caballi Species 0.000 description 1
- 241000219429 Betula Species 0.000 description 1
- 235000003932 Betula Nutrition 0.000 description 1
- 241000238658 Blattella Species 0.000 description 1
- 208000003508 Botulism Diseases 0.000 description 1
- 241000701083 Bovine alphaherpesvirus 1 Species 0.000 description 1
- 241000711443 Bovine coronavirus Species 0.000 description 1
- 241000711895 Bovine orthopneumovirus Species 0.000 description 1
- 101800004538 Bradykinin Proteins 0.000 description 1
- 241000589568 Brucella ovis Species 0.000 description 1
- 206010006500 Brucellosis Diseases 0.000 description 1
- 102100036848 C-C motif chemokine 20 Human genes 0.000 description 1
- 241000589874 Campylobacter fetus Species 0.000 description 1
- 241000680578 Canid alphaherpesvirus 1 Species 0.000 description 1
- 241000711506 Canine coronavirus Species 0.000 description 1
- 241000701931 Canine parvovirus Species 0.000 description 1
- 102100027473 Cartilage oligomeric matrix protein Human genes 0.000 description 1
- 101710176668 Cartilage oligomeric matrix protein Proteins 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 102000016289 Cell Adhesion Molecules Human genes 0.000 description 1
- 108010067225 Cell Adhesion Molecules Proteins 0.000 description 1
- 208000024699 Chagas disease Diseases 0.000 description 1
- 241000725585 Chicken anemia virus Species 0.000 description 1
- 241001647372 Chlamydia pneumoniae Species 0.000 description 1
- 241000606153 Chlamydia trachomatis Species 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 241000710777 Classical swine fever virus Species 0.000 description 1
- 241000193155 Clostridium botulinum Species 0.000 description 1
- 241000193468 Clostridium perfringens Species 0.000 description 1
- 241000272201 Columbiformes Species 0.000 description 1
- OMFXVFTZEKFJBZ-UHFFFAOYSA-N Corticosterone Natural products O=C1CCC2(C)C3C(O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 OMFXVFTZEKFJBZ-UHFFFAOYSA-N 0.000 description 1
- 102400000739 Corticotropin Human genes 0.000 description 1
- 101800000414 Corticotropin Proteins 0.000 description 1
- 241000606678 Coxiella burnetii Species 0.000 description 1
- 102000003915 DNA Topoisomerases Human genes 0.000 description 1
- 108090000323 DNA Topoisomerases Proteins 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- ZAHDXEIQWWLQQL-IHRRRGAJSA-N Deoxypyridinoline Chemical compound OC(=O)[C@@H](N)CCCC[N+]1=CC(O)=C(C[C@H](N)C([O-])=O)C(CC[C@H](N)C(O)=O)=C1 ZAHDXEIQWWLQQL-IHRRRGAJSA-N 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 101150029707 ERBB2 gene Proteins 0.000 description 1
- 241000605312 Ehrlichia canis Species 0.000 description 1
- 241000701148 Equine adenovirus Species 0.000 description 1
- 241000710803 Equine arteritis virus Species 0.000 description 1
- 241000230501 Equine herpesvirus sp. Species 0.000 description 1
- 241000713730 Equine infectious anemia virus Species 0.000 description 1
- 101000867232 Escherichia coli Heat-stable enterotoxin II Proteins 0.000 description 1
- 108010008165 Etanercept Proteins 0.000 description 1
- 108010008177 Fd immunoglobulins Proteins 0.000 description 1
- 241000714201 Feline calicivirus Species 0.000 description 1
- 241000713800 Feline immunodeficiency virus Species 0.000 description 1
- 241000711475 Feline infectious peritonitis virus Species 0.000 description 1
- 241000714165 Feline leukemia virus Species 0.000 description 1
- 241000701915 Feline panleukopenia virus Species 0.000 description 1
- 241000282324 Felis Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 101710128530 Fibrinogen-binding protein Proteins 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 102400000921 Gastrin Human genes 0.000 description 1
- 108010052343 Gastrins Proteins 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 102400000321 Glucagon Human genes 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- 102000007648 Glutathione S-Transferase pi Human genes 0.000 description 1
- 108010007355 Glutathione S-Transferase pi Proteins 0.000 description 1
- QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 description 1
- 102000006354 HLA-DR Antigens Human genes 0.000 description 1
- 108010058597 HLA-DR Antigens Proteins 0.000 description 1
- 108700010013 HMGB1 Proteins 0.000 description 1
- 101150021904 HMGB1 gene Proteins 0.000 description 1
- 241000606768 Haemophilus influenzae Species 0.000 description 1
- 241000711549 Hepacivirus C Species 0.000 description 1
- 208000005176 Hepatitis C Diseases 0.000 description 1
- 208000005331 Hepatitis D Diseases 0.000 description 1
- 206010019773 Hepatitis G Diseases 0.000 description 1
- 102100037907 High mobility group protein B1 Human genes 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000713099 Homo sapiens C-C motif chemokine 20 Proteins 0.000 description 1
- 101000858088 Homo sapiens C-X-C motif chemokine 10 Proteins 0.000 description 1
- 101001069921 Homo sapiens Growth-regulated alpha protein Proteins 0.000 description 1
- 101000972485 Homo sapiens Lupus La protein Proteins 0.000 description 1
- 102000003864 Human Follicle Stimulating Hormone Human genes 0.000 description 1
- 108010082302 Human Follicle Stimulating Hormone Proteins 0.000 description 1
- 241000701044 Human gammaherpesvirus 4 Species 0.000 description 1
- 241000701806 Human papillomavirus Species 0.000 description 1
- 108010058683 Immobilized Proteins Proteins 0.000 description 1
- 241000712431 Influenza A virus Species 0.000 description 1
- 102000008070 Interferon-gamma Human genes 0.000 description 1
- 108010074328 Interferon-gamma Proteins 0.000 description 1
- 102000051628 Interleukin-1 receptor antagonist Human genes 0.000 description 1
- 108700021006 Interleukin-1 receptor antagonist Proteins 0.000 description 1
- 102100026018 Interleukin-1 receptor antagonist protein Human genes 0.000 description 1
- 101710144554 Interleukin-1 receptor antagonist protein Proteins 0.000 description 1
- 102000000704 Interleukin-7 Human genes 0.000 description 1
- 241000721662 Juniperus Species 0.000 description 1
- 102100035792 Kininogen-1 Human genes 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 102100022742 Lupus La protein Human genes 0.000 description 1
- 241000555688 Malassezia furfur Species 0.000 description 1
- 244000141359 Malus pumila Species 0.000 description 1
- 235000011430 Malus pumila Nutrition 0.000 description 1
- 235000015103 Malus silvestris Nutrition 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 102000000440 Melanoma-associated antigen Human genes 0.000 description 1
- 108050008953 Melanoma-associated antigen Proteins 0.000 description 1
- 102000014962 Monocyte Chemoattractant Proteins Human genes 0.000 description 1
- 108010064136 Monocyte Chemoattractant Proteins Proteins 0.000 description 1
- 241000588655 Moraxella catarrhalis Species 0.000 description 1
- 241000187482 Mycobacterium avium subsp. paratuberculosis Species 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 241001138504 Mycoplasma bovis Species 0.000 description 1
- 241000202934 Mycoplasma pneumoniae Species 0.000 description 1
- 102100030856 Myoglobin Human genes 0.000 description 1
- 108010062374 Myoglobin Proteins 0.000 description 1
- 241001147662 Neospora caninum Species 0.000 description 1
- 108010025020 Nerve Growth Factor Proteins 0.000 description 1
- 102000007072 Nerve Growth Factors Human genes 0.000 description 1
- 102000007999 Nuclear Proteins Human genes 0.000 description 1
- 108010089610 Nuclear Proteins Proteins 0.000 description 1
- 241000277275 Oncorhynchus mykiss Species 0.000 description 1
- 108010035042 Osteoprotegerin Proteins 0.000 description 1
- 102000008108 Osteoprotegerin Human genes 0.000 description 1
- 241000283898 Ovis Species 0.000 description 1
- 102100034574 P protein Human genes 0.000 description 1
- 101710181008 P protein Proteins 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 101710171522 Peroxidase 50 Proteins 0.000 description 1
- FQYUMYWMJTYZTK-UHFFFAOYSA-N Phenyl glycidyl ether Chemical compound C1OC1COC1=CC=CC=C1 FQYUMYWMJTYZTK-UHFFFAOYSA-N 0.000 description 1
- 241000746981 Phleum Species 0.000 description 1
- 101710177166 Phosphoprotein Proteins 0.000 description 1
- 108010082093 Placenta Growth Factor Proteins 0.000 description 1
- 102000004576 Placental Lactogen Human genes 0.000 description 1
- 108010003044 Placental Lactogen Proteins 0.000 description 1
- 239000000381 Placental Lactogen Substances 0.000 description 1
- 206010035148 Plague Diseases 0.000 description 1
- 102000013566 Plasminogen Human genes 0.000 description 1
- 108010051456 Plasminogen Proteins 0.000 description 1
- 102000010752 Plasminogen Inactivators Human genes 0.000 description 1
- 108010077971 Plasminogen Inactivators Proteins 0.000 description 1
- 241000595626 Plodia Species 0.000 description 1
- 241001135989 Porcine reproductive and respiratory syndrome virus Species 0.000 description 1
- 241000711493 Porcine respiratory coronavirus Species 0.000 description 1
- 241000702665 Porcine rotavirus Species 0.000 description 1
- 108010085648 Pregnancy-Specific beta 1-Glycoproteins Proteins 0.000 description 1
- 102100022018 Pregnancy-specific beta-1-glycoprotein 8 Human genes 0.000 description 1
- 108010048233 Procalcitonin Proteins 0.000 description 1
- 102100025803 Progesterone receptor Human genes 0.000 description 1
- 241000196250 Prototheca Species 0.000 description 1
- LCYXYLLJXMAEMT-SAXRGWBVSA-N Pyridinoline Chemical compound OC(=O)[C@@H](N)CCC1=C[N+](C[C@H](O)CC[C@H](N)C([O-])=O)=CC(O)=C1C[C@H](N)C(O)=O LCYXYLLJXMAEMT-SAXRGWBVSA-N 0.000 description 1
- 206010037688 Q fever Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 108010027647 Replication Protein C Proteins 0.000 description 1
- 102000018779 Replication Protein C Human genes 0.000 description 1
- 206010051497 Rhinotracheitis Diseases 0.000 description 1
- 241000606701 Rickettsia Species 0.000 description 1
- 241000606699 Rickettsia conorii Species 0.000 description 1
- 241000606695 Rickettsia rickettsii Species 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 102000005686 Serum Globulins Human genes 0.000 description 1
- 108010045362 Serum Globulins Proteins 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 208000021386 Sjogren Syndrome Diseases 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 240000006694 Stellaria media Species 0.000 description 1
- 241000193985 Streptococcus agalactiae Species 0.000 description 1
- 241000194048 Streptococcus equi Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 241001505901 Streptococcus sp. 'group A' Species 0.000 description 1
- 241000194054 Streptococcus uberis Species 0.000 description 1
- 238000003854 Surface Print Methods 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 101150109894 TGFA gene Proteins 0.000 description 1
- 102000046283 TNF-Related Apoptosis-Inducing Ligand Human genes 0.000 description 1
- 241000223776 Theileria equi Species 0.000 description 1
- 102000004338 Transferrin Human genes 0.000 description 1
- 108090000901 Transferrin Proteins 0.000 description 1
- 229940123445 Tricyclic antidepressant Drugs 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 241001058196 Tritrichomonas foetus Species 0.000 description 1
- 102100036859 Troponin I, cardiac muscle Human genes 0.000 description 1
- 101710128251 Troponin I, cardiac muscle Proteins 0.000 description 1
- 108090001108 Troponin T Proteins 0.000 description 1
- 102000004987 Troponin T Human genes 0.000 description 1
- 102100039094 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 102100031358 Urokinase-type plasminogen activator Human genes 0.000 description 1
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
- 208000018756 Variant Creutzfeldt-Jakob disease Diseases 0.000 description 1
- 241000607598 Vibrio Species 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 241000713325 Visna/maedi virus Species 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 229960003697 abatacept Drugs 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 108010023082 activin A Proteins 0.000 description 1
- 229960002964 adalimumab Drugs 0.000 description 1
- 239000012082 adaptor molecule Substances 0.000 description 1
- 239000012790 adhesive layer Substances 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229960002478 aldosterone Drugs 0.000 description 1
- 229960000548 alemtuzumab Drugs 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229960004238 anakinra Drugs 0.000 description 1
- 239000002870 angiogenesis inducing agent Substances 0.000 description 1
- 230000001745 anti-biotin effect Effects 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 230000003460 anti-nuclear Effects 0.000 description 1
- 230000009830 antibody antigen interaction Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000013096 assay test Methods 0.000 description 1
- 201000008680 babesiosis Diseases 0.000 description 1
- 229940065181 bacillus anthracis Drugs 0.000 description 1
- 229940125717 barbiturate Drugs 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 208000005881 bovine spongiform encephalopathy Diseases 0.000 description 1
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229930003827 cannabinoid Natural products 0.000 description 1
- 239000003557 cannabinoid Substances 0.000 description 1
- 229940065144 cannabinoids Drugs 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 229960005395 cetuximab Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- AOXOCDRNSPFDPE-UKEONUMOSA-N chembl413654 Chemical compound C([C@H](C(=O)NCC(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@@H](N)CCC(O)=O)C1=CC=C(O)C=C1 AOXOCDRNSPFDPE-UKEONUMOSA-N 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 229940038705 chlamydia trachomatis Drugs 0.000 description 1
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical class O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 1
- 208000037933 contagious bovine pleuropneumonia Diseases 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- OMFXVFTZEKFJBZ-HJTSIMOOSA-N corticosterone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@H](CC4)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OMFXVFTZEKFJBZ-HJTSIMOOSA-N 0.000 description 1
- 229960000258 corticotropin Drugs 0.000 description 1
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 1
- 239000007819 coupling partner Substances 0.000 description 1
- 238000012864 cross contamination Methods 0.000 description 1
- 108010073131 cystic fibrosis serum factor Proteins 0.000 description 1
- 108010057085 cytokine receptors Proteins 0.000 description 1
- 102000003675 cytokine receptors Human genes 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- ZGSPNIOCEDOHGS-UHFFFAOYSA-L disodium [3-[2,3-di(octadeca-9,12-dienoyloxy)propoxy-oxidophosphoryl]oxy-2-hydroxypropyl] 2,3-di(octadeca-9,12-dienoyloxy)propyl phosphate Chemical compound [Na+].[Na+].CCCCCC=CCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCC=CCCCCC)COP([O-])(=O)OCC(O)COP([O-])(=O)OCC(OC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC ZGSPNIOCEDOHGS-UHFFFAOYSA-L 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229940051998 ehrlichia canis Drugs 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 231100000655 enterotoxin Toxicity 0.000 description 1
- 239000005447 environmental material Substances 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- PROQIPRRNZUXQM-ZXXIGWHRSA-N estriol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H]([C@H](O)C4)O)[C@@H]4[C@@H]3CCC2=C1 PROQIPRRNZUXQM-ZXXIGWHRSA-N 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 108010038795 estrogen receptors Proteins 0.000 description 1
- 102000015694 estrogen receptors Human genes 0.000 description 1
- JKKFKPJIXZFSSB-CBZIJGRNSA-N estrone 3-sulfate Chemical compound OS(=O)(=O)OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 JKKFKPJIXZFSSB-CBZIJGRNSA-N 0.000 description 1
- 229960000403 etanercept Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000013861 fat-free Nutrition 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 239000013568 food allergen Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 244000000036 gastrointestinal pathogen Species 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229960000578 gemtuzumab Drugs 0.000 description 1
- 229960004666 glucagon Drugs 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 229940047650 haemophilus influenzae Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 201000010284 hepatitis E Diseases 0.000 description 1
- 229940022353 herceptin Drugs 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000012203 high throughput assay Methods 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 102000052611 human IL6 Human genes 0.000 description 1
- 229960001001 ibritumomab tiuxetan Drugs 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 238000002991 immunohistochemical analysis Methods 0.000 description 1
- 239000012770 industrial material Substances 0.000 description 1
- 229960000598 infliximab Drugs 0.000 description 1
- 108010067471 inhibin A Proteins 0.000 description 1
- 229960003130 interferon gamma Drugs 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 108010023015 ischemia-modified albumin Proteins 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000001592 luteinising effect Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229960001797 methadone Drugs 0.000 description 1
- 229940062713 mite extract Drugs 0.000 description 1
- 238000011512 multiplexed immunoassay Methods 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 229940013390 mycoplasma pneumoniae Drugs 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 230000001452 natriuretic effect Effects 0.000 description 1
- 230000000508 neurotrophic effect Effects 0.000 description 1
- 239000003900 neurotrophic factor Substances 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 230000036963 noncompetitive effect Effects 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 239000000101 novel biomarker Substances 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- XXUPLYBCNPLTIW-UHFFFAOYSA-N octadec-7-ynoic acid Chemical compound CCCCCCCCCCC#CCCCCCC(O)=O XXUPLYBCNPLTIW-UHFFFAOYSA-N 0.000 description 1
- 229940127240 opiate Drugs 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 239000013610 patient sample Substances 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000002797 plasminogen activator inhibitor Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229950008882 polysorbate Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229920000131 polyvinylidene Polymers 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- CWCXERYKLSEGEZ-KDKHKZEGSA-N procalcitonin Chemical compound C([C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)NCC(O)=O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@@H](N)CSSC1)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 CWCXERYKLSEGEZ-KDKHKZEGSA-N 0.000 description 1
- 108090000468 progesterone receptors Proteins 0.000 description 1
- 150000003815 prostacyclins Chemical class 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 239000011546 protein dye Substances 0.000 description 1
- 239000012474 protein marker Substances 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 229940075118 rickettsia rickettsii Drugs 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000003118 sandwich ELISA Methods 0.000 description 1
- 238000007423 screening assay Methods 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 229940115922 streptococcus uberis Drugs 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 1
- 150000003595 thromboxanes Chemical class 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 229960005267 tositumomab Drugs 0.000 description 1
- 239000012581 transferrin Substances 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 229960000575 trastuzumab Drugs 0.000 description 1
- 239000003029 tricyclic antidepressant agent Substances 0.000 description 1
- 229940035722 triiodothyronine Drugs 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 229940118696 vibrio cholerae Drugs 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 108010047303 von Willebrand Factor Proteins 0.000 description 1
- 102100036537 von Willebrand factor Human genes 0.000 description 1
- 229960001134 von willebrand factor Drugs 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5025—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures for parallel transport of multiple samples
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/508—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
- B01L3/5085—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above for multiple samples, e.g. microtitration plates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/508—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
- B01L3/5085—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above for multiple samples, e.g. microtitration plates
- B01L3/50855—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above for multiple samples, e.g. microtitration plates using modular assemblies of strips or of individual wells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Clinical Laboratory Science (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86177106P | 2006-11-28 | 2006-11-28 | |
| US60/861,771 | 2006-11-28 | ||
| PCT/US2007/082732 WO2008067091A2 (en) | 2006-11-28 | 2007-10-26 | Assay membrane and method of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2670615A1 CA2670615A1 (en) | 2008-06-05 |
| CA2670615C true CA2670615C (en) | 2018-05-01 |
Family
ID=39468589
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2670615A Active CA2670615C (en) | 2006-11-28 | 2007-10-26 | Assay membrane and method of use thereof |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US9625453B2 (enExample) |
| EP (1) | EP2092333B1 (enExample) |
| JP (1) | JP5240945B2 (enExample) |
| AU (1) | AU2007325465B2 (enExample) |
| CA (1) | CA2670615C (enExample) |
| ES (1) | ES2422597T3 (enExample) |
| NZ (1) | NZ577992A (enExample) |
| WO (1) | WO2008067091A2 (enExample) |
| ZA (1) | ZA200903411B (enExample) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2092333B1 (en) * | 2006-11-28 | 2013-05-01 | Pictor Limited | Assay membrane and method of use thereof |
| CA2818483C (en) * | 2010-11-17 | 2020-12-15 | Aushon Biosystems | Method of and system for printing in-well calibration features |
| ES2926726T3 (es) | 2011-11-14 | 2022-10-27 | Aushon Biosystems Inc | Sistemas y métodos para mejorar la consistencia del rendimiento de un ensayo |
| CN104781415A (zh) | 2012-06-28 | 2015-07-15 | 卡尔德拉健康有限责任公司 | 用于诊断前列腺癌的靶向RNA-Seq的方法和材料 |
| US9427707B2 (en) | 2012-08-10 | 2016-08-30 | Jean I. Montagu | Filtering blood |
| WO2015009907A1 (en) | 2013-07-17 | 2015-01-22 | The Johns Hopkins University | A multi-protein biomarker assay for brain injury detection and outcome |
| GB201314452D0 (en) * | 2013-08-13 | 2013-09-25 | Ostara Biomedical Ltd | Embryo implantation |
| US10619210B2 (en) | 2014-02-07 | 2020-04-14 | The Johns Hopkins University | Predicting response to epigenetic drug therapy |
| FR3019654B1 (fr) | 2014-04-04 | 2020-10-30 | Bio Rad Innovations | Controles pour la mise en oeuvre de procedes d'analyse multiplexe |
| US9903868B2 (en) | 2014-05-16 | 2018-02-27 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Method for the detection and quantitation of biomarkers |
| US10222386B2 (en) | 2014-09-19 | 2019-03-05 | The Johns Hopkins University | Biomarkers of congnitive dysfunction |
| GB201501302D0 (en) | 2015-01-27 | 2015-03-11 | Ostara Biomedical Ltd | Embryo implantation |
| EP3259594A4 (en) | 2015-02-20 | 2018-12-26 | The Johns Hopkins University | Biomarkers of myocardial injury |
| GB201517523D0 (en) | 2015-10-05 | 2015-11-18 | Ostara Biomedical Ltd | Methods and compositions for managing reproduction |
| US10973679B2 (en) * | 2016-02-12 | 2021-04-13 | Adam Arreola | STD detecting condom |
| CA3054571A1 (en) | 2017-02-24 | 2018-08-30 | Board Of Regents,The University Of Texas System | Assay for detection of early stage pancreatic cancer |
| US11117128B2 (en) * | 2017-08-25 | 2021-09-14 | Vanadis Diagnostics Ab | Filtration device |
| US11547747B2 (en) | 2017-09-27 | 2023-01-10 | University Of Georgia Research Foundation, Inc. | Treatment and detection of infection and disease associated with different fungal pathogens |
| JP7347849B2 (ja) * | 2018-04-19 | 2023-09-20 | ファースト ライト ダイアグノスティクス， インコーポレイテッド | 標的の検出 |
| CA3127340A1 (en) | 2019-01-24 | 2020-07-30 | University Of Georgia Research Foundation | Treatment and detection of infection and disease associated with different fungal pathogens |
| WO2020264156A1 (en) | 2019-06-25 | 2020-12-30 | Musc Foundation For Research Development | Asymmetric dimethylarginine (adma) as a marker for vascular pathologies |
| US20210325380A1 (en) * | 2020-04-20 | 2021-10-21 | EnLiSense, LLC | Disease diagnostics using a multi-configurable sensing array |
| CN111796101B (zh) * | 2020-07-14 | 2022-08-26 | 汕头市中心医院 | Notch3蛋白表达量检测剂联合cypa蛋白表达量检测剂在预测癌症治疗疗效的用途 |
| CN116547537A (zh) * | 2020-07-29 | 2023-08-04 | 皮克托有限公司 | SARS-CoV-2抗体免疫测定 |
| WO2022025773A1 (en) * | 2020-07-29 | 2022-02-03 | Pictor Limited | Immunoassay for sars-cov-2 antibodies |
| US20240295549A1 (en) * | 2020-08-07 | 2024-09-05 | Vital Biosciences Inc. | Multiplexed analyte detection |
| WO2022039604A1 (en) * | 2020-08-21 | 2022-02-24 | Pictor Limited | Multiplex assay for johne's disease and pregnancy |
| WO2022072479A1 (en) | 2020-09-29 | 2022-04-07 | The Johns Hopkins University | Integrated proteomic biomarkers for the detection of aggressive prostate cancer |
| WO2022119459A1 (en) * | 2020-12-03 | 2022-06-09 | Pictor Limited | Device and method of analyte detection |
| WO2022193028A1 (en) * | 2021-03-19 | 2022-09-22 | Kenota Inc. | Assay membrane test region localization |
| CN113070113B (zh) * | 2021-06-03 | 2021-08-20 | 成都齐碳科技有限公司 | 芯片结构、成膜方法、纳米孔测序装置及应用 |
| CN113791210B (zh) * | 2021-09-17 | 2024-10-29 | 石家庄洹众生物科技有限公司 | 一种同时检测基质金属蛋白酶-8和白细胞介素-6的试剂条、装置及其应用 |
| CN116519956A (zh) * | 2023-04-19 | 2023-08-01 | 三诺生物传感股份有限公司 | 一种降钙素原校准品基质液 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6417324B1 (en) * | 2000-04-21 | 2002-07-09 | Tripep Ab | Synthetic peptides that bind to the hepatitis B virus core and e antigens |
| AU8662598A (en) | 1998-07-22 | 2000-02-14 | Syntron Bioresearch, Inc. | Multiple analyte assay device |
| US6942771B1 (en) | 1999-04-21 | 2005-09-13 | Clinical Micro Sensors, Inc. | Microfluidic systems in the electrochemical detection of target analytes |
| US6753143B2 (en) | 2000-05-01 | 2004-06-22 | Clinical Micro Sensors, Inc. | Target analyte detection using asymmetrical self-assembled monolayers |
| US6699665B1 (en) * | 2000-11-08 | 2004-03-02 | Surface Logix, Inc. | Multiple array system for integrating bioarrays |
| DE60233301D1 (de) * | 2001-05-04 | 2009-09-24 | Biosite Inc | Diagnostische marker für akute herzerkrankungen und verfahren des gebrauchs |
| US7063979B2 (en) * | 2001-06-13 | 2006-06-20 | Grace Bio Labs., Inc. | Interface between substrates having microarrays and microtiter plates |
| US20050153381A1 (en) * | 2002-02-14 | 2005-07-14 | Marusich Michael F. | Immunocapture of mitochondrial protein complexes |
| US20030153013A1 (en) * | 2002-11-07 | 2003-08-14 | Ruo-Pan Huang | Antibody-based protein array system |
| CA2509063C (en) * | 2002-11-16 | 2010-11-02 | Dade Behring Marburg Gmbh | Scd40l and placental growth factor (plgf) as biochemical marker combinations in cardiovascular diseases |
| US20040191810A1 (en) * | 2002-12-17 | 2004-09-30 | Affymetrix, Inc. | Immersed microarrays in conical wells |
| US7074194B2 (en) * | 2003-05-19 | 2006-07-11 | Ischemia Technologies, Inc. | Apparatus and method for risk stratification of patients with chest pain of suspected cardiac origin |
| CN100357738C (zh) * | 2004-03-26 | 2007-12-26 | 博奥生物有限公司 | 一种检测小分子化合物的方法 |
| US20060024703A1 (en) * | 2004-06-01 | 2006-02-02 | The Regents Of The University Of Michigan | Library on a slide and the use thereof |
| US7662573B2 (en) * | 2004-08-18 | 2010-02-16 | The United States Of America As Represented By The Department Of Health And Human Services | Methods for evaluating osteoarthritis risk |
| WO2006105147A2 (en) * | 2005-03-28 | 2006-10-05 | Bioseek, Inc. | Biological dataset profiling of cardiovascular disease and cardiovascular inflammation |
| EP1877553B1 (en) | 2005-05-02 | 2011-01-19 | ANP Technologies, Inc. | Polymer conjugate enhanced bioassays |
| WO2008036802A2 (en) | 2006-09-21 | 2008-03-27 | Prometheus Laboratories Inc. | Antibody-based arrays for detecting multiple signal transducers in rare circulating cells |
| EP2092333B1 (en) * | 2006-11-28 | 2013-05-01 | Pictor Limited | Assay membrane and method of use thereof |
-
2007
- 2007-10-26 EP EP07863577.8A patent/EP2092333B1/en active Active
- 2007-10-26 ES ES07863577T patent/ES2422597T3/es active Active
- 2007-10-26 CA CA2670615A patent/CA2670615C/en active Active
- 2007-10-26 US US12/513,659 patent/US9625453B2/en active Active
- 2007-10-26 JP JP2009539389A patent/JP5240945B2/ja not_active Expired - Fee Related
- 2007-10-26 NZ NZ577992A patent/NZ577992A/xx unknown
- 2007-10-26 AU AU2007325465A patent/AU2007325465B2/en not_active Ceased
- 2007-10-26 WO PCT/US2007/082732 patent/WO2008067091A2/en not_active Ceased
-
2009
- 2009-05-18 ZA ZA200903411A patent/ZA200903411B/xx unknown
-
2017
- 2017-04-18 US US15/490,795 patent/US10948486B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20100093557A1 (en) | 2010-04-15 |
| EP2092333A2 (en) | 2009-08-26 |
| WO2008067091A3 (en) | 2008-08-28 |
| US9625453B2 (en) | 2017-04-18 |
| ZA200903411B (en) | 2010-03-31 |
| EP2092333A4 (en) | 2010-01-20 |
| US10948486B2 (en) | 2021-03-16 |
| US20180067109A1 (en) | 2018-03-08 |
| AU2007325465A1 (en) | 2008-06-05 |
| WO2008067091A2 (en) | 2008-06-05 |
| EP2092333B1 (en) | 2013-05-01 |
| AU2007325465B2 (en) | 2013-09-05 |
| NZ577992A (en) | 2012-09-28 |
| JP5240945B2 (ja) | 2013-07-17 |
| JP2010511177A (ja) | 2010-04-08 |
| CA2670615A1 (en) | 2008-06-05 |
| ES2422597T3 (es) | 2013-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10948486B2 (en) | Assay membrane and method of use thereof | |
| US12453971B2 (en) | Cartridge and system for analyzing body liquid | |
| EP3475702B1 (en) | Measuring trail by lateral flow immunoassay | |
| Knight et al. | Development of a sensitive microarray immunoassay and comparison with standard enzyme-linked immunoassay for cytokine analysis | |
| US11635387B2 (en) | Optical imaging system using lateral illumination for digital assays | |
| EP1848998A2 (en) | Method of adjusting the working range of a multi-analyte assay | |
| CN1700009A (zh) | 用单一捕获剂定量检测特异性分析物的方法及其试剂盒 | |
| Manole et al. | Immunoassay techniques highlighting biomarkers in immunogenetic diseases | |
| JP2024057619A (ja) | ウイルス感染と細菌感染を区別するためのマルチプレックスラテラルフローアッセイ | |
| CN103823058B (zh) | 血清中抗原类蛋白的化学发光蛋白芯片方法和试剂盒 | |
| JP2024061719A (ja) | ウイルス感染と細菌感染を区別するためのマルチプレックスラテラルフローアッセイ | |
| CN109781972B (zh) | 一种免疫定量检测方法和应用 | |
| US20220034904A1 (en) | IMMUNOASSAY FOR SARS-CoV-2 ANTIBODIES | |
| KR20160110701A (ko) | 막 기반 다중튜브를 포함하는 생체 물질 분석 장치 | |
| CA3175366A1 (en) | Simultaneous detection of humoral and inflammatory biomarkers | |
| Gannot et al. | Layered peptide arrays: high-throughput antibody screening of clinical samples | |
| CN212748940U (zh) | 多种抗原抗体检测一体式反应管 | |
| JP5714791B2 (ja) | 非特異反応抑制剤 | |
| JP2007147494A (ja) | 同時物質測定方法およびそれに使用する測定用支持体 | |
| CN109313190A (zh) | 通过流体样品再利用而使流体样品多重化的设备、方法和试剂盒 | |
| Matson | Lateral Flow Microarray-Based ELISA for Cytokines | |
| WO2005119258A1 (ja) | 複数物質同時測定方法およびそれに使用する測定用デバイス | |
| CN120121848B (zh) | 一种用于检测难溶性蛋白的胶体金试剂盒及检测方法 | |
| WO2002073180A1 (en) | An antibody-based protein array system | |
| CA2845807A1 (en) | Calibration reagent and method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |